Landos Biopharma

$2.94 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Landos Biopharma

Landos Biopharma, Inc. operates as a pharmaceutical company. The Company discovers and develops oral therapeutics for patients with autoimmune diseases. Landos Biopharma serves customers worldwide.

Stock Analysis

last close $2.94
1-mo return -44.1%
3-mo return -80.1%
avg daily vol. 50.12T
52-week high 16.99
52-week low 2.91
market cap. $150M
forward pe -
annual div. -
roe -119.4%
ltg forecast -
dividend yield -
annual rev. $18M
inst own. 56.5%
baraka

Subscribe now for daily local and international financial news

Subscribe